Laura Coates comments on the results from the EXCEED trial, which showed that secukinumab has similar musculoskeletal efficacy to adalimumab in biologic-naïve patients with psoriatic arthritis (3:51).
04-06-2020 | EULAR 2020 conference hub | Conference coverage | Video